Status:

COMPLETED

Effect of the Biomarker Copeptin in Managing Patients With Suspected Acute Coronary Syndrome (ACS)

Lead Sponsor:

Charite University, Berlin, Germany

Collaborating Sponsors:

Kerckhoff Klinik

Heidelberg University

Conditions:

Acute Myocardial Infarction

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Acute chest pain is commonly known to be the classic symptom of acute myocardial infarction. Of the many patients which visit the Emergency Department because of chest pain, less than half do actually...

Detailed Description

The management of patients with suspected Non-ST elevation acute coronary syndrome (NSTEACS) can be time-consuming and expensive. Often patients need to be hospitalized for precautionary medical treat...

Eligibility Criteria

Inclusion

  • Typical chest pain (with or without ECG-changes, but no ST-elevation)suggestive of unstable angina or non-ST-elevated myocardial infarction (NSTEMI)
  • Troponin negative at admission according to the current clinical practice Patient willing and able to give written informed consent

Exclusion

  • Patients with ST-elevation myocardial infarction (STEMI)
  • Continuing chest pain or recurrent episodes of chest pain under therapy
  • High-risk patients with suspected ACS who need to be hospitalized for reasons independent of their initial troponin result
  • Patients who need to be hospitalized for other medical reasons
  • Patients in need of urgent life-saving interventions
  • Patients under 18 years of age
  • Patients with a life expectancy \< 6 months
  • Patients with any condition that leads the treating physician to not consider the patient eligible for the trial

Key Trial Info

Start Date :

April 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2013

Estimated Enrollment :

902 Patients enrolled

Trial Details

Trial ID

NCT01498731

Start Date

April 1 2011

End Date

June 1 2013

Last Update

June 5 2013

Active Locations (6)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (6 locations)

1

Wilhelminenspital Vienna

Vienna, Austria, 1160

2

Kerckhoff-Klinik GmbH

Bad Nauheim, Germany, 61231

3

Charité - Universitätsmedizin Berlin

Berlin, Germany, 13353

4

Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany, 20246

Effect of the Biomarker Copeptin in Managing Patients With Suspected Acute Coronary Syndrome (ACS) | DecenTrialz